about
The influence of subclonal resistance mutations on targeted cancer therapyT lymphocytes targeting native receptorsNovel diet-related mouse model of colon cancer parallels human colon cancerDetecting ultralow-frequency mutations by Duplex Sequencing.Molecular landscape and sub-classification of gastrointestinal cancers: a review of literature.Genome-wide analysis of loss of heterozygosity in breast infiltrating ductal carcinoma distant normal tissue highlights arm specific enrichment and expansion across tumor stages.Direct involvement of retinoblastoma family proteins in DNA repair by non-homologous end-joining.Sequencing small genomic targets with high efficiency and extreme accuracy.MIPSTR: a method for multiplex genotyping of germline and somatic STR variation across many individuals.Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNAA new kink in an old theory of carcinogenesisHeterozygous colon cancer-associated mutations of SAMHD1 have functional significanceSequence capture by hybridization to explore modern and ancient genomic diversity in model and nonmodel organisms.BRCA2 and TP53 collaborate in tumorigenesis in zebrafish.Comprehensive Proteomic Characterization of the Human Colorectal Carcinoma Reveals Signature Proteins and Perturbed Pathways.Methods: for studying pharmacogenetic profiles of combination chemotherapeutic drugs.Regulation of cytokinesis and its clinical significance.Cancer stem cells: A product of clonal evolution?The VerIFAST: an integrated method for cell isolation and extracellular/intracellular staining.Current status and future prospects for human papillomavirus vaccines.p16 controls epithelial cell growth and suppresses carcinogenesis through mechanisms that do not require RB1 function.Stress-induced transposon reactivation: a mediator or an estimator of allostatic load?
P2860
Q26781693-8BFE6915-2E4B-49FB-9220-9D147888CA6EQ26853345-F12D2854-7D1A-4008-9914-B544A74D4AA6Q28243913-3383C55F-98A1-4F77-AD48-E7740F1B9428Q30413211-C1AD36E9-86E8-40BC-B877-D9AFF2E415D6Q33895591-61416BA8-5959-4EF5-8C55-C8B462493717Q35153040-597F709B-C06F-4D08-A2E3-6BE21B9AF570Q35275846-FFF9CBDC-DD3C-4C94-A31B-3B2BF55E3E52Q35554760-52A613B6-C78A-4A34-A2E6-3E15BC6688F8Q35561975-78E0B54E-61A5-4B0D-B9A2-F8504BA83F93Q36128449-87CE1BE0-0F46-4CF9-9AD7-378C9CC91478Q36687317-063CDD82-3449-4DD2-8D70-3CD4590DB055Q36866147-DD609222-9AB7-4628-842B-137A0B53DD2FQ36959108-4DBA31BF-3EF9-4C56-B52A-B56D0FCC199CQ37529633-638EEAEB-B69F-4378-8D10-9E6EE802DE27Q37633338-C38572DD-301B-4D5A-AFDE-1410B79D9D17Q38513661-2256B7D7-6439-47CC-9A2A-7059215B9152Q38535644-4405A07F-DA8E-41B4-A168-C463FFE3DC6BQ38965946-1CC4E6E8-E725-4392-8EB8-CE58F6DBC7D8Q39229886-792A389C-7C3E-4482-A783-2FB95032C584Q40056541-1022F3C8-E43F-4CD8-8DCD-B5EE2F7B5CEEQ41080919-578CADBB-7574-4BE1-B1E3-03BFA84AACD5Q50351263-0DAB6A7F-44FC-43AF-97DE-16C8C990B2C8
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Implications of genetic heterogeneity in cancer
@ast
Implications of genetic heterogeneity in cancer
@en
Implications of genetic heterogeneity in cancer
@nl
type
label
Implications of genetic heterogeneity in cancer
@ast
Implications of genetic heterogeneity in cancer
@en
Implications of genetic heterogeneity in cancer
@nl
prefLabel
Implications of genetic heterogeneity in cancer
@ast
Implications of genetic heterogeneity in cancer
@en
Implications of genetic heterogeneity in cancer
@nl
P2093
P2860
P3181
P1476
Implications of genetic heterogeneity in cancer
@en
P2093
Lawrence A Loeb
Marc J Prindle
Michael W Schmitt
P2860
P3181
P356
10.1111/J.1749-6632.2012.06590.X
P407
P577
2012-09-01T00:00:00Z